GOSS - Gossamer Bio secures option to acquire Respira Therapeutics September, 25 2025 08:00 AM Gossamer Bio Inc. 2025-09-25 08:00:57 ET More on Gossamer Bio Gossamer Bio: Bullish Ahead Of Seralutinib's Phase 3 Readout Gossamer Bio: A Critical Year Ahead Gossamer Bio higher as UBS upgrades on upcoming data catalyst Seeking Alpha’s Quant Rating on Gossamer Bio Historical earnings data for Gossamer Bio For further details see: Gossamer Bio secures option to acquire Respira Therapeutics